# Nortech Systems Inc: Form 10-Q for the period ended Jun 30, 2011

- Company: [Nortech Systems Inc](/companies/nsys.md) (CIK 722313)
- Form: 10-Q
- Filed: 2011-08-12
- Accepted by EDGAR: Aug 12, 2011, 10:08 ET
- Period: 2011-06-30
- Accession: 0001104659-11-046379
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/722313/000110465911046379/a11-13961_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/722313/000110465911046379/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2011-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2011-04-01 to 2011-06-30 | $27.8m | us-gaap:SalesRevenueNet |
| Revenue | 6 months, 2011-01-01 to 2011-06-30 | $56.8m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2011-04-01 to 2011-06-30 | $24.6m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2011-01-01 to 2011-06-30 | $50.4m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2011-04-01 to 2011-06-30 | $3.2m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2011-01-01 to 2011-06-30 | $6.4m | us-gaap:GrossProfit |
| Operating income | 3 months, 2011-04-01 to 2011-06-30 | $339.1k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2011-01-01 to 2011-06-30 | $625.8k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2011-04-01 to 2011-06-30 | $142.1k | us-gaap:InterestExpense |
| Interest expense | 6 months, 2011-01-01 to 2011-06-30 | $262.1k | us-gaap:InterestExpense |
| Income tax | 3 months, 2011-04-01 to 2011-06-30 | $24.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2011-01-01 to 2011-06-30 | $337.0k | us-gaap:IncomeTaxExpenseBenefit |
| Diluted EPS | 3 months, 2011-04-01 to 2011-06-30 | $0.05 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months, 2011-01-01 to 2011-06-30 | $0.28 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted shares (weighted) | 3 months, 2011-04-01 to 2011-06-30 | 2,742,992 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2011-01-01 to 2011-06-30 | 2,742,992 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2011-01-01 to 2011-06-30 | −$4.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2011-01-01 to 2011-06-30 | $355.1k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2011-06-30 | $1.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2011-06-30 | $42.0m | us-gaap:AssetsCurrent |
| Total assets | at 2011-06-30 | $51.7m | us-gaap:Assets |
| Current liabilities | at 2011-06-30 | $30.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2011-06-30 | $31.6m | us-gaap:Liabilities |
| Long-term debt | at 2011-06-30 | $908.5k | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2011-06-30 | $2.7m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2011-06-30 | $20.1m | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |

## Management's discussion and analysis

As filed, 15,661 characters.

#### Overview:

We are a Wayzata, Minnesota based full-service Electronics Manufacturing Services (EMS) contract manufacturer of wire and cable assemblies, printed circuit board assemblies, higher-level assemblies and box builds for a wide range of industries. We provide value added services and technical support including design, testing, prototyping and supply chain management to customers mainly in the Aerospace and Defense, Medical, and Industrial Equipment markets. We maintain manufacturing facilities in Baxter, Bemidji, Blue Earth, Fairmont, Mankato, Merrifield, and Milaca, Minnesota; Augusta, Wisconsin; and Monterrey, Mexico.

Summary of Results:

For the quarter ended June 30, 2011, we reported net sales of $27.8 million compared to $24.7 million reported in the same quarter of 2010, a 13% improvement. For the six months ended

June 30, 2011, we reported net sales of $56.8 million compared to $46.4 million reported for the first six months of 2010, an increase of 22%. This growth was a direct result of our recent acquisitions. Our 90-day backlog increased 14% from the start of the quarter to $22.8 million as of June 30, 2011. This compares to $21.3 million for the same period last year.

Our gross profit in the second quarter of 2011 was 11.6% compared to 12.6% in the second quarter of 2010. Gross profit in the first six months of 2011 was 11.3% compared to 12.4% in the first six months of 2010. The profit percentage decrease is mainly attributed to the reinstatement of wages, incentives and benefits that had been suspended in the first six months of 2010, and absorbing the cost of integrating our acquisitions offset by a positive product mix and our lean initiatives.

Income from operations totaled $0.3 million and $0.6 million for the three and six months ended June 30, 2011, respectively. Income from operations totaled $0.5 million and $0.8 million for the three and six months ended June 30, 2010, respectively. The decreases in 2011 were a result of lower gross profit.

Net income for the second quarter of 2011 totaled $0.1 million or $0.05 per diluted common share. Net income for the six months ended June 30, 2011 totaled $0.8 million or $0.28 per diluted common share; $0.3 million or $0.08 per diluted common share excluding the bargain purchase gain of $0.5 million, net of tax. Net income totaled $0.1 million and $0.2 million for the three and six months ended June 30, 2010.

Cash used in operating activities for the six months ended June 30, 2011 was $4.7 million compared to cash provided by operating activities of $0.4 million for the same period in 2010. Cash used in the second quarter of 2011 decreased to $0.8 million from cash used of $3.9 million in the first quarter of 2011. The revenue growth and related working capital requirements, primarily increases in inventories, accounted for the majority of the usage.

(1.) Results of Operations:

The following table presents statements of income data as percentages of total net sales for the periods indicated:

|  | Three Months Ended June 30 2011 | 2010 | Six Months Ended June 30 2011 | 2010 |
| --- | ---: | ---: | ---: | ---: |
| Net Sales | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of Goods Sold | 88.4 | 87.4 | 88.7 | 87.6 |
| Gross Profit | 11.6 | 12.6 | 11.3 | 12.4 |
| Selling Expenses | 3.1 | 3.1 | 3.2 | 3.3 |
| General and Administrative Expenses | 7.3 | 7.5 | 7.0 | 7.3 |
| Income from Operations | 1.2 | 2.0 | 1.1 | 1.8 |
| Bargain Purchase Gain | 0.0 | 0.0 | 1.4 | 0.0 |
| Other Expenses, Net | (0.6) | (0.4) | (0.5) | (0.6) |
| Income Before Income Taxes | 0.6 | 1.6 | 2.0 | 1.2 |
| Income Tax Expense | 0.1 | 1.0 | 0.6 | 0.7 |
| Net Income | 0.5% | 0.6% | 1.4% | 0.5% |

Net Sales:

We reported net sales of $27.8 million and $24.7 million for the three months ended June 30, 2011 and 2010, respectively. Sales for the six months ended June 30, 2011 and 2010 were $56.8 million and $46.4 million, respectively. The 2011 net sales were impacted by our two recent acquisitions; the Milaca medical device operation acquired in May 2010 accounted for incremental increases in net sales of $0.6 million and $2.1 million for the three and six months ended June 30, 2011, respectively; while the Mankato operation acquired in January 2011 accounted for $4.6 million and $8.6 million of additional net sales for the three and six months ended June 30, 2011, respectively. These increases were offset in part by declines in the Aerospace and Defense market as discussed below.

Net sales by industry markets for the three month period ended June 30, 2011 and 2010 are as follows:

|  | Three Months Ended June 30 | Six Months Ended June 30 |
| --- | ---: | ---: |
|  | **2011** **2010%** | **2011** **2010%** |
| **(in thousands)** | **$$** **Change** | **$$** **Change** |
| Aerospace and Defense | 2,764 3,445 (20) | 7,175 8,073 (11) |
| Medical | 7,781 6,567 18 | 15,790 11,960 32 |
| Industrial | 17,251 14,683 17 | 33,830 26,403 28 |
| Total Sales | 27,796 24,695 13 | 56,795 46,436 22 |

Net sales to our Aerospace and Defense customers for the three and six months ended June 30, 2011 were lower than the three and six months ended June 30, 2010 as a result of the timing of Federal funding of defense contracts due to delays in budget approvals. The increase in net sales to our Medical customers of $1.2 million for the three months ended June 30, 2011 was primarily due to the Mankato acquisition which generated $1.0 million in additional net sales. The increase in net sales to our Medical customers of $3.8 million for the six months ended June 30, 2011 relates primarily to the Mankato and Milaca acquisitions, which added $1.7 million and $2.4 million, respectively, offset by a $0.3 decrease at the other locations. The Mankato acquisition also impacted the Industrial customers by $3.6 million and $6.9 million for the three and six months ending June 30, 2011, respectively.

Backlog:

Our 90-day order backlog as of June 30, 2011 was approximately $22.8 million, compared to approximately $20.0 million at the beginning of the quarter and $21.3 million at June 30, 2010. Backlog by industry market is shown below.

*(in thousands)*

|  | Backlog as of the Quarter Ended June 30 2011 | March 31% 2011 | Change |
| --- | ---: | ---: | ---: |
| Aerospace and Defense | $4,025 | $2,796 | 44 |
| Medical | 6,314 | 5,325 | 19 |
| Industrial | 12,445 | 11,895 | 5 |
| Total Backlog | $22,784 | $20,016 | 14 |

The Aerospace and Defense backlog increased as federal funding emerged on several key programs during the second quarter. The Medical backlog increased $1.0 million or 19% and the Industrial backlog increased $0.6 million or 5% over the March 31, 2011 backlog.

Gross Profit:

Gross profit percentage for the three months ended June 30, 2011 and 2010 was 11.6% and 12.6% of net sales, respectively. Gross profit percentage for the six months ended June 30, 2011 and 2010 was 11.3% and 12.4%, respectively. Our gross profit percentage decreased due to the reinstatement of wages, incentives and benefits that had been suspended in the first six months of 2010, and absorbing the cost of integrating our acquisitions offset by a positive product mix and our lean initiatives.

Selling Expense:

We had selling expenses of $0.9 million or 3.1% of net sales and $0.8 million or 3.1% of net sales for the three months ended June 30, 2011 and 2010, respectively. Selling expenses were $1.8 million or 3.2% of net sales and $1.5 million or 3.3% of net sales for the six months ended June 30, 2011 and 2010, respectively. Selling expense as a percent of sales remains lower than historical levels due to continued efforts to control spending. We anticipate increased investment in selling and business development activities to support the expected increase in revenue levels and growth from our recent acquisitions.

General and Administrative Expense:

Our general and administrative expenses were $2.0 million or 7.3% of net sales and $1.9 million or 7.5% of net sales for the three months ended June 30, 2011 and 2010, respectively. General and administrative expenses were $4.0 million or 7.0% of net sales and $3.4 million or 7.3% of net sales for the six months ended June 30, 2011 and 2010, respectively. The increase in general and administrative dollars spent in 2011 is primarily attributed to costs incurred with our recent acquisitions.

Other Income (Expense):

Other expense for the three months ended June 30, 2011 and 2010 was $0.2 million and $0.1 million, respectively. The increase in the second quarter relates primarily to higher interest expense and negative exchange rate fluctuations. Other income for the six months ended June 30, 2011 was $0.5 million, while other expense for the six months ended June 30, 2010 was $0.3 million. The increase in other income over the first six months of 2011 is primarily due to recognizing a bargain purchase gain of $0.8 million from the Mankato acquisition in the first quarter of 2011.

Income Taxes:

Our effective tax rate for the three and six months ended June 30, 2011 was 14.1% and 30.4%, respectively, compared with 62.5% and 55.7% for the three and six months ended June 30, 2010, respectively. The differences between federal income taxes computed at the federal statutory rate and reported income taxes for the three and six months ended June 30, 2011 are as follows:

|  | Three Months Ended June 30 2011 | 2010 | Six Months Ended June 30 2011 | 2010 |
| --- | ---: | ---: | ---: | ---: |
| Statutory federal tax provision | $58,000 | $137,000 | $377,000 | $190,000 |
| State income taxes | 6,000 | 11,000 | 33,000 | 16,000 |
| Income tax credits | (16,000) | (2,000) | (32,000) | (4,000) |
| NOL carryback true up | — | 101,000 | — | 111,000 |
| Tax authority closing agreement | (96,000) | — | (96,000) | — |
| Reserve for uncertain tax positions | 90,000 | — | 90,000 | — |
| Other | (18,000) | (2,000) | (35,000) | (8,000) |
| Income tax expense | $24,000 | $245,000 | $337,000 | $305,000 |

#### Liquidity and Capital Resources:

We have satisfied our liquidity needs over the past several years through revenue generated from operations and an operating line of credit through WFB. Both the line of credit and real estate term note are subject to fluctuations in the LIBOR rates. The line of credit, real estate term note, and equipment loans with WFB contain certain covenants which, among other things, require us to adhere to regular reporting requirements, abide by annual shareholder dividend limitations, maintain certain financial performance, and limit the amount of annual capital expenditures. The availability under our line is subject to borrowing base requirements, and advances are at the discretion of the lender. The line of credit is secured by substantially all of our assets. On June 30, 2011, we had an outstanding balance of $12.3 million under the line of credit and unused availability of $0.9 million supported by our borrowing base. We believe our financing arrangements and cash flows provided by operations will be sufficient to satisfy our future working capital needs.

Our working capital of $11.5 million as of June 30, 2011 decreased from $13.1 million at December 31, 2010 mainly due to increased line of credit and current maturities of long term debt of $8.5 million, partially offset by increased inventories of $5.4 million and increased accounts receivable of $1.9 million. $4.2 million of the inventory increase and all of the accounts receivable increase relates to the Mankato operation. The inventory build from the Mankato acquisition has stabilized and a plan is in place to reduce inventories to current demand levels.

Net cash used in operating activities for the six months ended June 30, 2011 was $4.7 million. The cash flow used in operations for the six months ended June 30, 2011 is primarily the result of working capital requirements needed to support the Mankato operations, which included the purchase of approximately $4.2 million of inventory for production.

Net cash used in investing activities of $1.4 million for the six months ended June 30, 2011 is comprised of $0.4 million in property and equipment purchases to support the business and $1.0 million for the Mankato operation acquisition (see Note 6).

Net cash provided by financing activities for the six months ended June 30, 2011 was $7.3 million, mainly due to the increase in borrowing on the line of credit and notes payable of $8.1 million required to fund the Mankato acquisition and growth, partially offset by debt payments of $0.8 million.

#### Critical Accounting Policies and Estimates

Our significant accounting policies and estimates are summarized in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2010. There have been no significant changes in these critical accounting policies since December 31, 2010. Some of our accounting policies require us to exercise significant judgment in selecting the appropriate assumptions for calculating financial estimates. Such judgments are subject to an inherent degree of uncertainty. These judgments are based on our historical experience, known trends in our industry, terms of existing contracts and other information from outside sources, as appropriate. Actual results could differ from these estimates.

Forward-Looking Statements:

Those statements in the foregoing report that are not historical facts are forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements generally will be accompanied by words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “possible,” “potential,” “predict,” “project,” or other similar words that convey the uncertainty of future events or outcomes. Although we believe these forward-looking statements are reasonable, they are based upon a number of assumptions concerning future conditions, any or all of which may ultimately prove to be inaccurate. Forward-looking statements involve a number of risks and uncertainties.

Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation:

- Volatility in the marketplace which may affect market supply and demand for our products;
- Increased competition;
- Changes in the reliability and efficiency of operating facilities or those of third parties;
- Risks related to availability of labor;
- Increase in certain raw material costs such as copper;
- Commodity and energy cost instability;
- General economic, financial and business conditions that could affect our financial condition and results of operations;
- Successful integration of recent acquisitions

The factors identified above are believed to be important factors (but not necessarily all of the important factors) that could cause actual results to differ materially from those expressed in any forward-looking statement made by us. Unpredictable or unknown factors not discussed herein could also have material adverse effects on forward-looking statements. All forward-looking statements included in this Form 10-Q are expressly qualified in their entirety by the forgoing cautionary statements. We undertake no obligations to update publicly any forward-looking statement (or its associated cautionary language) whether as a result of new information or future events.

Please refer to forward-looking statements and risks as previously disclosed in our report on Form 10-K for the fiscal year ended December 31, 2010.

## Controls and procedures

As filed, 1,429 characters.

Evaluation of Disclosure Controls and Procedures:

In accordance with Rule 13a-15(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this Quarterly Report on Form 10-Q, our management evaluated, with the participation of our Chief Executive Officer and Executive Vice President and Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act). Based upon their evaluation of these disclosure controls and procedures, the Chief Executive Officer and Chief Financial Officer have concluded that the disclosure controls and procedures were effective as of the date of such evaluation in ensuring that information required to be disclosed in our Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting:

There was no change in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Filed Aug 12, 2011.
Source: SEC EDGAR, the filing index for accession 0001104659-11-046379. Last ingested by Listed: Nov 12, 2026, 19:20 ET. No prices; not investment advice.
